Researchers lift a corner of the veil of Depression
About 1 in 10 Europeans has to contend with some form of depression during his or her life. But how people become depressed is still largely a mystery. With their recent research, scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to the University of Antwerp in collaboration with scientists of the University of Umeå in Sweden, are lifting a corner of the veil. Their studies indicate that the TPH2 protein is involved in the development of depression and manic depression.
The role of serotonin
Depression and manic depression
Depression is one of the most prevalent disorders in the Western world, and, according to the World Health Organization, it will even be the No. 1 disorder in 2020. Ten to 15 per cent of the population - from all levels of society - experience depression during their lifetime; and about 5% has to contend with manic depression. Despite the high socio-economic costs and mortality rate, the causes of these psychiatric disorders are not yet known. However, scientists are in agreement that the origin of depression can be attributed to a combination of hereditary and environmental factors such as stress.
The hormone serotonin plays an important role in our brain chemistry. The amount of serotonin in the brain has a large influence on our thinking, emotions and behavior. Because antidepressants affect the level of serotonin in the brain, it has long been suspected that serotonin plays a role in the development of psychiatric disorders. So, the amount of serotonin that you produce and keep under control appears to be crucial in the fight against (manic) depression. Because the TPH2 protein is instrumental in regulating the serotonin level, scientists suspect that TPH2 plays a role in the development of psychiatric disorders.
Ann Van Den Bogaert and her colleagues from the research group of Jurgen Del-Favero have also been studying the role of TPH2 in the development of depression and manic depression. They have conducted a genetic study in which they compared the variation in the TPH2 gene between patients with depression and healthy individuals. The DNA of two random individuals are 99.9% identical - the 0.1% that is different contains the genetic variation that can originate disorders.
In collaboration with the Swedish research group under the direction of Rolf Adolfsson and Karl-Fredrik Norrback, the researchers studied the DNA of hundreds of Swedish patients with depression and manic depression and that of healthy control subjects. By comparing the genetic variations between the patients and healthy individuals, they have shown that in this Swedish population TPH2 is involved in the development of depression and manic depression.
Thus, their research brings us a step closer to a better understanding of these psychiatric disorders.
Sooike Stoops | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
So-called pre-distorted states accelerate photochemical reactions too
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...